LEDIPASVIR AND SOFOSBUVIR

19121 reported adverse events

Drug classes: Hepatitis C Virus NS5A Inhibitor [EPC] Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LEDIPASVIR AND SOFOSBUVIR:

# Side effect Count
0 FATIGUE 4131
1 HEADACHE 3707
2 NAUSEA 1242
3 DRUG INEFFECTIVE 1140
4 DIARRHOEA 913
5 HEPATITIS C 887
6 INSOMNIA 835
7 VOMITING 442
8 DIZZINESS 440
9 DRUG DOSE OMISSION 436
See all common reactions for LEDIPASVIR AND SOFOSBUVIR

LEDIPASVIR AND SOFOSBUVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATITIS C VIRUS TEST POSITIVE 105 0.1786
1 HEPATIC CANCER RECURRENT 45 0.1585
2 CEREBRAL HYGROMA 6 0.1304
3 GENOTYPE DRUG RESISTANCE TEST POSITIVE 112 0.1089
4 HEPATITIS C RNA 5 0.1087
5 HEPATITIS C RNA POSITIVE 14 0.0819
6 ECTOPIC KIDNEY 7 0.0737
7 HEPATITIS C 887 0.0734
8 HEPATOCELLULAR CARCINOMA 402 0.0528
9 LARYNGOMALACIA 13 0.0387
See all enriched reactions for LEDIPASVIR AND SOFOSBUVIR